Business & Regulation

Business & Regulation Standards & Regulation

01/22/2024 | Stephanie Vine

A video tour of the top FDA approvals from 2023

Business & Regulation Digital Technologies

01/11/2024 | Jamie Irvine

Nick Armstrong, Senior Director of Digital Enablement at CAI, discusses the realities of digital enablement, artificial intelligence, and more.

Business & Regulation Profession

01/05/2024 | Stephanie Vine

Get your pharma heroes nominated by January 12!

Business & Regulation Profession

01/02/2024 | Jamie Irvine

Our roundup of some of our thoughtful and inspiring video interviews and roundtables from the past year.

Business & Regulation Profession

12/28/2023 | Stephanie Vine | 4 min read

Exploring the gaps and opportunities in Canada’s cell and gene workforce.

Business & Regulation Business Practice

12/19/2023

Ali Pashazadeh from Treehill Partners offers his advice for navigating the turbulent period and keeping on track for commercial success.

Business & Regulation Business Practice

12/13/2023 | Stephanie Vine | 10 min read

From renewable energy to bicycle schemes and more; here are just a few examples of how a pharma business can be more sustainable.

Business & Regulation Quality & Compliance

12/08/2023 | Jamie Irvine | 4 min read

The details and reactions behind a recent FDA investigation into the cancer-risk of CAR-T therapies

Business & Regulation Business Practice

12/06/2023 | Marijn Verhoef, Martijn van Gerven | 5 min read

Experts from the Access to Medicine Foundation discuss how to reduce the risk of antimicrobial resistance (AMR) in antibiotic manufacturing.

Business & Regulation Standards & Regulation

12/04/2023 | Sumukhi Sreevatsan | 3 min read

How do we encourage the development of new cell and gene therapies without compromising our ethics?